Dentin Hypersensitivity in Orthodontic Patients: Triple-Blinded, Randomized Trial of Three Desensitizing Agents.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: TOOTH PASTE(NHA), TOOTH PASTE (NOVAMIN), TOOTH PASTE (PROARGIN), TOOTH PASTE ( NON DESENSITIZING).
- Who it may be relevant to
- Registry conditions: Dentin Desensitizing Agents. Basic parameters: 18 years — 40 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Dentin Hypersensitivity: Triple-Blinded, Multicenter Randomized Trial of Three Desensitizing Dentifrices vs Non-Desensitizing Control
Overview
The effect of desensitizing agents will be studied on dentin hypersensitivity in orthodontic patients.it is a randomized controlled trial. three experimental groups and one placebo group.
Interventions
- Other TOOTH PASTE(NHA)
TOOTH PASTES CONTAINING NHA. - Other TOOTH PASTE (NOVAMIN)
TOOTH PASTE CONTAINING NOVAMIN - Other TOOTH PASTE (PROARGIN)
TOOTH PASTE CONTAINING PROARGIN. - Other TOOTH PASTE ( NON DESENSITIZING)
TOOTH PASTE A NON-DESENSITIZING CONTROL
Primary outcome measures
- REDUCTION IN DENTIN HYPERSENSITIVITY [Time frame: 8 WEEKS]
Eligibility criteria
Inclusion criteria
- Orthodontic patients aged 18-40 years.
- Presence of mild to moderate dentin hypersensitivity (VAS ≥ 4).
- Willingness to comply with a 12-week follow-up period.
- No active periodontal disease or untreated caries.
- Not pregnant or breastfeeding.
- No history of allergy to desensitizing agents
Exclusion criteria
- o Patients with systemic conditions affecting oral health (e.g., diabetes, immunocompromised).
- Patients using medications that affect tooth sensitivity (e.g., anti-inflammatory drugs).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Prevention
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07641322 · room 203 fk orthodontics